Volume 28, Number 6—June 2022
Research
Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016
Table 2
Clinician visits and duration of costs incurred, by Lyme disease category, in high-incidence areas, United States, 2014–2016
Characteristic |
All |
Lyme disease category |
||
Confirmed localized |
Confirmed disseminated |
Probable |
||
Median provider visits (range) | 2 (1–47) | 2 (1–25) | 3 (1–45) | 2 (1–47) |
Median surveys* (range) | 3 (1–12) | 2 (1–12) | 3 (1–12) | 4 (1–12) |
*Participants began taking surveys at study enrollment and continued at approximately 1-month intervals until they reported no Lyme disease–related expenses for 2 consecutive surveys or when they completed the maximum of 12 surveys. The following were collected on all surveys: dates for Lyme disease–related healthcare visits, clinician contact information, patient medical costs, nonmedical costs, and productivity losses.